¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"maternal mortality ratio"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • proportionate mortality rate
    ºñ·Ê»ç¸Á·ü
  • perinatal mortality
    Ãâ»ýÀüÈıâ»ç¸Á·ü, ÁÖ»ê±â»ç¸Á·ü
  • perinatal mortality rate
    Ãâ»ýÀüÈıâ»ç¸Á·ü, ÁÖ»ê±â»ç¸Á·ü
  • specific mortality rate
    ƯÀÌ»ç¸Á·ü, ºñ»ç¸Á·ü
  • maternal
    ¸ð¼º-, ¸ðü-, ¸ð°è-
  • maternal and child health
    ¸ðÀÚº¸°Ç
  • maternal antibody
    ¸ðüÇ×ü
  • maternal behavior
    ¸ð¼ºÇൿ
  • maternal blood
    ¸ðüÇ÷¾×
  • maternal cotyledon
    ¸ðüÂÊŹݿ±
  • maternal death
    ¸ð¼º»ç¸Á
  • maternal deprivation
    ¸ð¼º¹ÚÅ»
  • maternal deprivation syndrome
    ¸ð¼º¹ÚÅ»ÁõÈıº
  • maternal dystocia
    ¸ðü¼º³­»ê
  • maternal feeding
    ¸ðÀ¯¿µ¾ç
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • signal-to-noise ratio
    ½ÅÈ£´ëÀâÀ½ºñ
  • uptake ratio
    ¼·ÃëÀ²
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • maternal line
    ¸ð°è
  • maternal
    ¸ð¼º-
  • maternal part
    ¸ðüºÎºÐ
  • maternal placenta
    ¸ðÃ¼ÃøÅ¹Ý
  • maternal welfare
    ¸ð¼ºº¹Áö
  • maternal deprivation syndrome
    ¸ð¼º¹ÚÅ»ÁõÈıº
  • mortality rate curve
    »ç¸Á·ü°î¼±
  • early neonatal mortality rate
    ½Å»ý¾Æ»ç¸Á·ü
  • excess mortality
    Ãʰú»ç¸Á·ü
  • hebdomadal mortality rate
    »ýÈÄÀÏÁÖ°£»ç¸Á·ü
  • infant mortality rate
    ¿µ¾Æ»ç¸Á·ü
  • mortality
    »ç¸Á·ü
  • mortality rate
    »ç¸Á·ü
  • national population mortality
    ±¹¹Î»ç¸Á·ü
  • neonatal mortality
    ½Å»ý¾Æ»ç¸Á·ü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • L/S ratio
    L/S ºñÀ²
  • OER [=oxygen enhancement ratio]
    »ê¼Ò°­È­À²
  • S-D ratio
    ¼öÃà±â-À̿ϱ⠺ñ (â¥õêÑ¢-ì¬èÐÑ¢ Ýï)
  • SNR (signal to noise ratio)
    ½ÅÈ£´ë ÀâÀ½ºñÀ²
  • V/Q => ventilation/perfusion ratio
    ȯ±â/°ü·ùºñ
  • VA/Q => ventilation/perfusion ratio
    ȯ±â/°ü·ù ºñ
  • air entrainment ratio
    °ø±âÀ¯ÀÔ·ü.
  • air pollution ratio
    ´ë±â¿À¿°·ü(ÊÙËô).
  • albumin CSF/serum ratio
    ¾ËºÎ¹Î ³úô¼ö¾×/Ç÷û ºñ
  • albumin-globulin ratio =A£¯G r.
    ¾ËºÎ¹Î ±Û·ÎºÒ¸°ºñ.
  • albumin/globulin ratio
    ¾ËºÎ¹Î/±Û·ÎºÒ¸° ºñ
  • alpha/beta (¥á/¥â) ratio
    ¥á/¥â ºñ
  • arm ratio
    µÎÆÈºñ(¡­Ýï).
  • gas exchange ratio
    °¡½º±³È¯ºñÀ²(ÎßüµÝï×Ë).
  • gyromagnetic ratio
    ȸÀü Àڱ⠺ñÀ²
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mortality rate
    »ç¸Á·ü(ÞÝØÌëÒ).
  • national population mortality
    ±¹¹Î»ç¸Á·ü(~Ë×ËÎËô).
  • neonatal mortality
    ½Å»ý¾Æ»ç¸Á(·ü)(~ÞÝØÌëÒ).
  • neonatal mortality
    ½Å»ý¾Æ»ç¸Á(·ü)(~Ë×ËÎËô).
  • neonatal mortality rate
    ½Å»ý¾Æ»ç¸Á·ü.
  • operative mortality rate
    ¼ö¼ú»ç¸Á·ü.
  • perinatal mortality
    ÁÖ»ê±â»ç¸Á(Ì¡Ë×Ë»Ë×ËÎ).
  • perinatal mortality rate
    ÁÖ»ê±â»ç¸Á·ü(ÊÙË×ËÎËô).
  • population mortality table
    ±¹¹Î»ý¸íÇ¥(Ë´ËÑË×ËḬ̂), ±¹¹Î»ç¸Á·üÇ¥(Ë´ËÑË×ËÎ Ëô̰).
  • postneonatal mortality rate
    ÈĽŻý¾Æ»ç¸Á·ü(Ì·ËàË×ËâË×ËÎËô).
  • proportional mortality indicator
    ºÎºÐºñ»ç¸ÁÁö¼ö.
  • proportional mortality rate
    ºÎºÐºñ»ç¸Á·ü.
  • proportionate mortality
    »ç¸Áºñ(Ë×ËÎËÓ).
  • specific mortality rate
    ƯÁ¤»ç¸Á·ü(Ì¬Ëø Ë×ËÎËô).
  • toddler mortality rate
    À¯¾Æ»ç¸Á·ü(ËôËâ Ë×ËÎËô).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Donnan ratio
    µ·³­ À²(ëÒ)
  • extraction ratio
    ÃßÃâºñ(õÎõóÝï)
  • flux ratio method
    Çöô½º ºñÀ²¹ý(Ýï×ËÛö)
  • frictional ratio
    ¸¶Âûºñ(ؤóÍÝï)
  • G + C/A + T ratio
    G + C/A + T ºñ(Ýï)
  • gyromagnetic ratio
    ÀÚ±âȸÀü ºñ(í¸Ñ¨üÞï®Ýï)
  • ratio
    ºñÀ²(Ýï×Ë)
  • induction ratio
    À¯µµºñ(ë¯ÓôÝï)
  • inhibition ratio
    ÀúÇØÀ²(îÁúªëÒ)
  • L/S ratio
    L/S À²(ëÏ)
  • mass-action ratio
    Áú·®ÀÛ¿ëÀ²(òõÕáíÂéÄëÒ)
  • nucleo-cytoplasmic ratio
    ÇÙ(ú·).¼¼Æ÷Áú(á¬øàòõ) ºñ(Ýï)
  • packing ratio
    ÆäÅ·À²(ëÒ)
  • polarity ratio
    ±Ø¼º ºñÀ²(пàõÝï×Ë)
  • P:O ratio
    P/O ºñ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • velocity ratio
    ¼Óµµºñ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MHP hemiplegic migraine; maternal health program; maternal health program; medical center health plan; 1...
AR absolute risk; accounts receivable; achievement ratio; actinic reticuloid [syndrome]; active resista...
L/S lactase/sucrase [ratio]; lecithin/ sphingomyelin [ratio]; lipid/saccharide [ratio]; longitudinal sec...
SMR   1) Sex Maturity Rating;¼º(àõ)¼º¼÷µµ
  2) Standarized Mortality Ratio
ASMR age-standardized mortality ratio
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PCMR Proportionate cancer mortality ratio
PMR Proportionate Mortality Ratio
SMR Standard Mortality Ratio
SMR Standardised Mortality Ratio
L/S ratio Lecithin/sphingomyelin ratio
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cardiothoracic ratio
    ½ÉÈäºñ, ½ÉÈä°û ºñ, ½ÉÈä °è¼ö
  • cell color ratio
    Ç÷±¸»ö¼Òºñ, ÀûÇ÷±¸ »ö¼Òºñ
  • child woman ratio
    ¸ð¾Æ ºñÀ²
  • crown-root ratio
    Ä¡°ü´ë Ä¡±Ùºñ
  • curative ratio
    Ä¡À¯À²
  • death ratio
    »ç¸Áºñ
    µ¿ÀǾî=
  • effective ratio
    À¯È¿À²
    ¾î´À ÇѰè±îÁö´Â ¾àÁ¦ ¿ë·®°ú À¯È¿À²Àº ºñ·ÊÇÑ´Ù. ÇѰè À̻󿡼­´Â ºÎÀÛ¿ëÀÌ ³ªÅ¸³­´Ù.
  • expansion ratio
    ÆØÃ¢ºñ
  • innervation ratio
    ½Å°æ Áö¹è ºñ
  • magnetization transfer ratio
    ÀÚÈ­ Àü´Þ ºñÀ²
  • mercuryalloy ratio
    ¼öÀº Çձݺñ
  • monocyte lymphocyte ratio
    ´Ü±¸ ¸²ÇÁ±¸ºñ
  • optimal ratio
    ÃÖÀûºñ
  • optimum ratio
    ÃÖÀûºñ
  • phase ratio
    »óºñ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
hospital mortality A vital statistic measuring or recording the rate of death from any cause in hospitalised populations.
(12 Dec 1998)
neonatal mortality rate The number of children dying under 28 days of age divided by the number of live births that year. The neonatal mortality rate in the united states, which was 8.4 per 1,000 live births in 1980, declined to 5.8 per 1,000 live births in 1990.
(12 Dec 1998)
infant mortality Perinatal, neonatal, and infant deaths in a given population.
(12 Dec 1998)
infant mortality rate The number of children dying under a year of age divided by the number of live births that year. The infant mortality rate in the united states, which was 12.5 per 1,000 live births in 1980, fell to 9.2 per 1,000 live births in 1990.
(12 Dec 1998)
type II mortality <epidemiology> A mortality schedule in which all hosts are assumed to die at a constant rate. This constant rate is equal to the inverse of the life expectancy.
(05 Dec 1998)
type I mortality <epidemiology> A mortality schedule in which all hosts are assumed to live for a fixed number of years equal to the life expectancy.
(05 Dec 1998)
foetal mortality rate <epidemiology> The ratio of foetal deaths divided by the sum of the births (the live births + the foetal deaths) in that year. In the United States, the foetal mortality rate plummeted from 19.2 per 1,000 births in 1950 to 9.2 per 1,000 births in 1980.
(12 Dec 1998)
maternal Relating to or derived from the mother.
Origin: L. Maternus, fr. Mater, mother
(05 Mar 2000)
maternal age 35 and over Pregnancy in women 35 or more years of age. It is used for normal pregnancies and for problems of pregnancy occurring in a woman's late reproductive years. These include effects on the mother's physical and mental health as well as risks of perinatal mortality and foetal abnormality.
(12 Dec 1998)
maternal antibody Any antibody transferred from a mammalian mother transplacentally into the foetus. See under immunoglobulin for details of the classes of Ig that are transferred to the foetus.
(18 Nov 1997)
maternal behaviour The behaviour patterns associated with or characteristic of a mother.
(12 Dec 1998)
maternal-child health centres Facilities which administer the delivery of health care services to mothers and children.
(12 Dec 1998)
maternal-child nursing The nursing specialty that deals with the care of women throughout their pregnancy and childbirth and the care of their newborn children.
(12 Dec 1998)
maternal cotyledon A unit of the placenta made up of trophoblastic cells, fibrous tissue, and abundant blood vessels, which is visible grossly on the maternal surface as an irregularly shaped lobe circumscribed by a deep cleft and made up of a stem villus with numerous branching free villi and anchoring villi; placental vessels in the chorionic plate supply the stem villus and its branches, allowing gas and metabolite exchange across the trophoblastic layer with maternal blood in the intervillous space; traditionally called clinicians' cotyledon.
(05 Mar 2000)
maternal death Death of a woman while pregnant or within 42 days after the termination of gestation, irrespective of the duration and site of pregnancy and the cause of death; two periods are recognised in the 42-day interval: period 1 includes day 1 to day 7; period 2 includes day 8 to day 42. Maternal death's are further classified as:
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mass ratio
    Áú·®ºñ (ÃßÁøºÎ¸¦ Á¦¿ÜÇÑ ·ÎÄÏ º»Ã¼¿¡ ´ëÇÑ ÃÑÁß·®ÀÇ ºñÀ²,ÃßÁø¾à ÃæÀüÀ²)
  • payout ratio
    ¹è´ç ¼ºÇâ
  • priceearnings ratio
    ÁÖ°¡ ¼öÀÍ·ü 9
  • ratio
    ºñ;ºñÀ²
  • respiratory quotient (ratio)
    È£Èí·ü;È£Èíºñ(³»¹ñ´Â ź»ê°¡½ºÀÇ ¾ç°ú ¿ÜºÎ·ÎºÎÅÍ Èí¼öÇÏ´Â »ê¼Ò·®°úÀÇ ºñ)
  • risk-benefit ratio
    À§Ç輺°ú ¼öÀͼº°úÀÇ ºñÀ²
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á